Table 3.

Prescription of guideline-recommended medications for cardiovascular risk modification amongst patients with PAD

	Pre-intervention and presence of PAD (n = 83)	Post-intervention and presence of PAD (n = 75)	p-valuea
Anti-hypertensive agent, n (%)	Admission: 71 (85.5)	Admission: 63 (84.0)	0.77
	Discharge: 66 (79.5)	Discharge: 61 (81.3)
Antiplatelet agent, n (%)	Admission: 45 (54.2)	Admission: 55 (73.3)	0.005
	Discharge: 52 (62.7)	Discharge: 62 (82.7)
Statin or fibrate, n (%)	Admission: 52 (62.7)	Admission: 54 (72.0)	0.12
	Discharge: 55 (66.3)	Discharge: 58 (77.3)

PAD peripheral arterial disease

^ap-value refers to statistical significance on comparing rates at discharge across both groups